BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38738999)

  • 1. Pan-cancer analysis of LRRC59 with a focus on prognostic and immunological roles in hepatocellular carcinoma.
    Pan B; Cheng J; Tan W; Wu X; Fan Q; Fan L; Jiang M; Yu R; Cheng X; Deng Y
    Aging (Albany NY); 2024 May; 16(9):8171-8197. PubMed ID: 38738999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive prognostic and immunological analysis of Cullin2 in pan-cancer and its identification in hepatocellular carcinoma.
    Jia L; Zhang X; Zhou T; Xie J; Jin J; Zhang D; Zhu C; Wan R
    Aging (Albany NY); 2024 May; 16(10):8898-8921. PubMed ID: 38787355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
    Huang S; Sun L; Hou P; Liu K; Wu J
    Front Immunol; 2022; 13():944898. PubMed ID: 36148220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification.
    Ouyang G; Li Q; Wei Y; Dai W; Deng H; Liu Y; Li J; Li M; Luo S; Li S; Liang Y; Pan G; Yang J; Gan T
    Front Immunol; 2024; 15():1323199. PubMed ID: 38742112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of a stemness-based classifier for prognosis and immunotherapy response of hepatocellular carcinoma based on bioinformatics and machine-learning strategies.
    Chen E; Zou Z; Wang R; Liu J; Peng Z; Gan Z; Lin Z; Liu J
    Front Immunol; 2024; 15():1244392. PubMed ID: 38694506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIF18B as a regulator in tumor microenvironment accelerates tumor progression and triggers poor outcome in hepatocellular carcinoma.
    Qiu MJ; Zhang L; Chen YB; Zhu LS; Zhang B; Li QT; Yang SL; Xiong ZF
    Int J Biochem Cell Biol; 2021 Aug; 137():106037. PubMed ID: 34217812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mitochondrial unfolded protein response-related risk signature to predict prognosis, immunotherapy and sorafenib sensitivity in hepatocellular carcinoma.
    Zhang S; Guo H; Wang H; Liu X; Wang M; Liu X; Fan Y; Tan K
    Apoptosis; 2024 Jun; 29(5-6):768-784. PubMed ID: 38493408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM166 inhibits cell proliferation, migration and invasion in hepatocellular carcinoma via upregulating TP53.
    Yang J; Wang B; Xu Q; Yang Y; Hou L; Yin K; Guo Q; Hua Y; Zhang L; Li Y; Zhang J; Li N
    Mol Cell Biochem; 2021 Feb; 476(2):1151-1163. PubMed ID: 33200377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRC59 serves as a novel biomarker for predicting the progression and prognosis of bladder cancer.
    Zhang P; Xie X; Li C; Zhang C; Liang P
    Cancer Med; 2023 Oct; 12(19):19758-19776. PubMed ID: 37706625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constructing immune and prognostic features associated with ADCP in hepatocellular carcinoma and pan-cancer based on scRNA-seq and bulk RNA-seq.
    Zhang Z; Li Y; Quan Z; Li Y; Zhu L; Sun S; Chen X
    Front Immunol; 2024; 15():1397541. PubMed ID: 38774870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Pan-Cancer Genomic Analysis Reveals PHF19 as a Carcinogenic Indicator Related to Immune Infiltration and Prognosis of Hepatocellular Carcinoma.
    Zhu ZY; Tang N; Wang MF; Zhou JC; Wang JL; Ren HZ; Shi XL
    Front Immunol; 2021; 12():781087. PubMed ID: 35069553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity.
    Fan R; Liu F; Gong Q; Liu D; Tang S; Shen D
    Front Immunol; 2024; 15():1393801. PubMed ID: 38660302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of leucine-rich repeat-containing protein 59 (LRRC59) located in the endoplasmic reticulum as a novel prognostic factor for urothelial carcinoma.
    Pei L; Zhu Q; Zhuang X; Ruan H; Zhao Z; Qin H; Lin Q
    Transl Oncol; 2022 Sep; 23():101474. PubMed ID: 35816851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma.
    Xu JH; Guan YJ; Qiu ZD; Zhang X; Zi LL; Zhou Y; Chen C; Yu J; Zhang YC; Wang WX
    Oxid Med Cell Longev; 2021; 2021():6485871. PubMed ID: 34795841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
    Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
    BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment.
    Ma LN; Ma Y; Luo X; Ma ZM; Ma LN; Ding XC
    Sci Rep; 2024 May; 14(1):12149. PubMed ID: 38802416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
    Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
    J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
    Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
    J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipophagy-related gene RAB7A is involved in immune regulation and malignant progression in hepatocellular carcinoma.
    Liu Y; Ma J; Wang X; Liu P; Cai C; Han Y; Zeng S; Feng Z; Shen H
    Comput Biol Med; 2023 May; 158():106862. PubMed ID: 37044053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.